About Us‎ > ‎Latest News‎ > ‎

Update on drugs - from the MS Trust

posted 4 Mar 2014, 06:00 by Alan B.
Janice from the MS Trust has written to me with some really helpful clarification of the process by which new drugs become available to MSers. She has also given me the latest news about disease modifying drugs aimed at those with relapse remitting MS (RRMS). Here is what she said:

Making new drugs available for use on the NHS is a two step process

  • firstly the drug has to have an European licence (evaluates safety, clinical effectiveness and manufacturing standards)
  • secondly it needs to be appraised for value for money by Scottish Medicines Consortium to make it available on the NHS in Scotland (NICE does the same thing for the NHS in England and Wales).

 

Teriflunomide, alemtuzumab and dimethyl fumarate have European licences, and are currently being appraised for use by the NHS in Scotland.

 

Laquinimod has been refused an European licence; the manufacturer is appealing against the decision.  Appraisal won’t happen until the licence has been granted.

 

Scottish Medicines Consortium information on current submissions is listed on their website – this page lists all the drugs they are reviewing:

http://www.scottishmedicines.org.uk/SMC_Advice/Forthcoming_Submissions/Category?term=All

 

 

So in summary:

 

Teriflunomide (Aubagio) has been approved by NICE for the NHS in England and Wales.  Also being appraised for NHS Scotland (Scottish Medicines Consortium (SMC) decision due 10 March).

 

Alemtuzumab (Lemtrada) has been turned down by NICE for NHS use in England and Wales, though they will review again.  Also being appraised for NHS Scotland (SMC decision due 12 May).

 

Dimethyl fumarate (BG-12, Tecfidera) has recently been licensed by Europe and has been turned down by NICE for use in England and Wales, though they will review again.  Also being appraised for NHS Scotland (SMC decision due 7 April). 

 

Laquinimod (Nerventra) has been refused an European licence; the manufacturer is appealing against the decision. 

 


Thanks to Janice! If you are wondering what the situation is in Moray, contact the MS Specialist Nurse.

Comments